uPAR-uPA interaction inhibitors and methods for treating cancer
US9376406B2 · kind B2 · utility
0Cited by
6References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 2, 2012 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | Mar 26, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5008
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention described herein pertains to compounds, compositions and formulations comprising the compounds, and methods for use of the compounds, compositions and/or formulations in the treatment of diseases responsive to the inhibition of uPAR-uPA interactions, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.